(Q33892873)

29 July 2017

title

Recent breast cancer incidence trends according to hormone therapy use: the California Teachers Study cohort (English)

1 reference

29 July 2017

0 references

2

Christina A Clarke

1 reference

29 July 2017

12

Leslie Bernstein

1 reference

29 July 2017

7

Peggy Reynolds

1 reference

29 July 2017

9

Pamela L Horn-Ross

1 reference

29 July 2017

6

Susan L Neuhausen

1 reference

29 July 2017

8

Giske Ursin

1 reference

29 July 2017

3

Dennis Deapen

1 reference

29 July 2017

10

Daniel O Stram

1 reference

29 July 2017

11

Claire Templeman

1 reference

29 July 2017

5

Joan Largent

1 reference

29 July 2017

Sarah F Marshall

1

1 reference

29 July 2017

Katherine Henderson

series ordinal

4

1 reference

29 July 2017

publication date

8 January 2010

1 reference

29 July 2017

published in

Breast Cancer Research

1 reference

29 July 2017

volume

12

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

R4

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr2467

29 July 2017

exact match

0 references

cites work

Declining breast cancer incidence and decreased HRT use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

Declines in breast cancer after the WHI: apparent impact of hormone therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

The decrease in breast-cancer incidence in 2003 in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

Breast cancer and hormone-replacement therapy in the Million Women Study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004.

5 July 2018

1 reference

Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population

21 January 2018

1 reference

Changes in breast cancer incidence rates in the United States by histologic subtype and race/ethnicity, 1995 to 2004.

21 January 2018

1 reference

Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence.

21 January 2018

1 reference

A decline in breast-cancer incidence.

21 January 2018

1 reference

Declining breast cancer incidence and decreased HRT use.

21 January 2018

1 reference

Hormone replacement therapy, mammography screening and changing age-specific incidence rates of breast cancer: an ecological study comparing two European populations.

21 January 2018

1 reference

Breast cancer and hormone-replacement therapy: the Million Women Study

21 January 2018

1 reference

Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2880422

The natural history of breast carcinoma: what have we learned from screening?

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20064209

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/BCR2467

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference